Skip to main content

and
  1. Article

    Open Access

    Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations

    In an extensive genomic analysis of lung adenocarcinomas (LUADs), driver mutations have been recognized as potential targets for molecular therapy. However, there remain cases where target genes are not identi...

    Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa in Molecular Cancer (2024)

  2. Article

    Open Access

    Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity

    We characterized age at diagnosis and estimated sex differences for lung cancer and its histological subtypes among individuals who never smoke.

    Batel Blechter, Jason Y. Y. Wong, Li-Hsin Chien in British Journal of Cancer (2024)

  3. Article

    Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer

    Masayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi in British Journal of Cancer (2023)

  4. No Access

    Article

    Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer

    Delta-like ligand 3 (DLL3) is a therapeutic target in small-cell lung cancer (SCLC). However, how DLL3 expression status affects the tumor microenvironment (TME) and clinical outcomes in SCLC remains unclear.

    Masayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi in British Journal of Cancer (2023)

  5. No Access

    Article

    A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer

    This study aimed to elucidate the clinicopathological and molecular features of HER2-amplified and HER2-low colorectal cancers (CRCs). We also characterised HER2 expression statuses in CRCs focusing on their intr...

    Taiki Hashimoto, Daisuke Takayanagi, Junpei Yonemaru in British Journal of Cancer (2023)

  6. Article

    Open Access

    Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer

    We investigated the utility of a molecular classifier tool and genetic alterations for predicting prognosis in Japanese patients with endometrial cancer.

    Yuka Asami, Mayumi Kobayashi Kato, Kengo Hiranuma in British Journal of Cancer (2023)

  7. Article

    Open Access

    Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

    To promote precision oncology in clinical practice, the Japanese Society of Medical Oncology, the Japanese Society of Clinical Oncology, and the Japanese Cancer Association, jointly published “Clinical practic...

    Yoichi Naito, Hiroyuki Aburatani in International Journal of Clinical Oncology (2021)

  8. No Access

    Article

    Precision medicine for ovarian clear cell carcinoma based on gene alterations

    Ovarian clear cell carcinoma (OCCC) is a histological subtype of epithelial ovarian carcinoma prevalent in Asians. No clear therapeutic selection based on molecular profile has been implemented for this diseas...

    Takafumi Kuroda, Takashi Kohno in International Journal of Clinical Oncology (2020)

  9. No Access

    Article

    High-grade glioneuronal tumor with an ARHGEF2NTRK1 fusion gene

    Here, we report a highly unusual case of high-grade glioneuronal tumor with a neurotrophic tropomyosin receptor kinase (NTRK) fusion gene. A 13-year-old girl presented with headache and vomiting and MRI detected ...

    Kazuhiko Kurozumi, Yoshiko Nakano, Joji Ishida, Takehiro Tanaka in Brain Tumor Pathology (2019)

  10. No Access

    Article

    Identification of a novel KLC1–ROS1 fusion in a case of pediatric low-grade localized glioma

    The proto-oncogene tyrosine-protein kinase ROS1 (ROS1) is a tyrosine kinase that is closely related to anaplastic lymphoma kinase receptor (ALK). We describe a novel KLC1–ROS1 fusion identified in a case of pedia...

    Yoshiko Nakano, Arata Tomiyama, Takashi Kohno, Akihiko Yoshida in Brain Tumor Pathology (2019)

  11. Article

    Open Access

    The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report

    SMARCB1 (INI1) is a tumor-suppressor gene located at 22q11.2. Loss of SMARCB1 protein expression has been reported to be associated with atypical teratoid/rhabdoid tumors and malignant rhabdoid tumors of the kidn...

    Kazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, Takashi Kohno in BMC Cancer (2018)

  12. Article

    Open Access

    Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials

    It is still controversial whether comprehensive genome screening of target molecules by next generation sequencing (NGS) is needed to increase clinical efficacy of investigational drugs or accelerate drug deve...

    Yuko Tanabe, Hitoshi Ichikawa, Takashi Kohno, Hiroshi Yoshida in Molecular Cancer (2016)

  13. No Access

    Article

    Genetic alterations responsible for metastatic phenotypes of lung cancer cells

    It is now widely accepted that human carcinogenesis is a multi-step process and phenotypic changes during cancer progression reflect the sequential accumulation of genetic alterations in cells. Thus, in order ...

    Jun Yokota, Michiho Nishioka, Masachika Tani in Clinical & Experimental Metastasis (2003)